UBS rates ORI as Downgrade to Sell from Neutral
UBS is incorporating increasing headwinds for the Australasian explosives business into forecasts. This results in an earnings per share cut of 4-5% in FY14-16. On current multiples UBS believes the stock looks expensive relative to its cyclical industrial peers.
As near-term risk/reward is skewed to the downside, given the leverage to global coal markets, the broker reduces the rating to Sell from Neutral. Target is lowered to $19.50 from $21.67.
- Forums
- ASX - By Stock
- ORI
- UBS rates ORI as Downgrade to Sell from Neutral
ORI
orica limited
Add to My Watchlist
0.97%
!
$21.89

UBS rates ORI as Downgrade to Sell from Neutral
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$21.89 |
Change
0.210(0.97%) |
Mkt cap ! $10.43B |
Open | High | Low | Value | Volume |
$21.84 | $21.89 | $21.57 | $21.24M | 973.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2625 | $21.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.90 | 822 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2625 | 21.850 |
2 | 2548 | 21.770 |
1 | 1472 | 21.750 |
1 | 834 | 21.740 |
1 | 874 | 21.730 |
Price($) | Vol. | No. |
---|---|---|
21.900 | 822 | 1 |
21.910 | 865 | 1 |
21.920 | 906 | 1 |
21.930 | 947 | 2 |
21.950 | 4550 | 4 |
Last trade - 16.10pm 21/08/2025 (20 minute delay) ? |
Featured News
ORI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online